Prevalence of Osteoporosis Assessed by DXA and/or CT in Severe Obese Patients.
Fiche publication
Date publication
octobre 2022
Journal
Journal of clinical medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ALBUISSON Eliane, Pr QUILLIOT Didier
Tous les auteurs :
Halin M, Allado E, Albuisson E, Brunaud L, Chary-Valckenaere I, Loeuille D, Quilliot D, Fauny M
Lien Pubmed
Résumé
The primary objective was to evaluate bone fragility prevalence on dual X-ray absorptiometry (DXA) and computed tomography (CT) in patients with severe obesity. The secondary objective was to evaluate the risk factors for bone fragility. This monocentric study was conducted in patients with grade 2 and 3 obesity. Bone mineral density (BMD) and T-score were studied on DXA, and the scanographic bone attenuation coefficient of L1 (SBAC-L1) was measured on CT. Among the 1386 patients included, 1013 had undergone both DXA and CT within less than 2 years. The mean age was 48.4 (±11.4) years, 77.6% were women, and the mean BMI was 45.6 (±6.7) kg/m². Eight patients (0.8%) had osteoporosis in at least one site. The mean SBAC-L1 was 192.3 (±52.4) HU; 163 patients (16.1%) were under the threshold of 145 HU. Older age (OR[CI95] = 1.1 [1.08-1.16]), lower BMD on the femoral neck and spine (OR[CI95] = 0.04[0.005-0.33] and OR[CI95] = 0.001[0.0001-0.008], respectively), and higher lean mass (OR[CI95] = 1.1 [1.03-1.13]) were significantly associated with an SBAC-L1 ≤ 145 HU in multivariate analysis. Approximately 16% of patients with severe obesity were under the SBAC-L1 threshold, while less than 1% were classified as osteoporotic on DXA.
Mots clés
bone mineral density (BMD), dual-energy X-ray absorptiometry (DXA), obesity, scanographic bone attenuation coefficient (SBAC-L1), tomodensitometry/CT
Référence
J Clin Med. 2022 10 17;11(20):